Day One Stock Forecast - Naive Prediction
| DAWN Stock | USD 11.78 0.55 4.46% |
Day Stock outlook is based on your current time horizon.
The value of RSI of Day One's stock price is about 60 suggesting that the stock is rather overbought by investors as of today. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Day, making its price go up or down. Momentum 60
Buy Extended
Oversold | Overbought |
Using Day One hype-based prediction, you can estimate the value of Day One Biopharmaceuticals from the perspective of Day One response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Day One Biopharmaceuticals on the next trading day is expected to be 13.19 with a mean absolute deviation of 0.50 and the sum of the absolute errors of 30.79. Day One after-hype prediction price | USD 11.78 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Day One to cross-verify your projections. Day One Additional Predictive Modules
Most predictive techniques to examine Day price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Day using various technical indicators. When you analyze Day charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Day One Naive Prediction Price Forecast For the 29th of January
Given 90 days horizon, the Naive Prediction forecasted value of Day One Biopharmaceuticals on the next trading day is expected to be 13.19 with a mean absolute deviation of 0.50, mean absolute percentage error of 0.38, and the sum of the absolute errors of 30.79.Please note that although there have been many attempts to predict Day Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Day One's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Day One Stock Forecast Pattern
| Backtest Day One | Day One Price Prediction | Buy or Sell Advice |
Day One Forecasted Value
In the context of forecasting Day One's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Day One's downside and upside margins for the forecasting period are 6.26 and 20.11, respectively. We have considered Day One's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Day One stock data series using in forecasting. Note that when a statistical model is used to represent Day One stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.1498 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.5048 |
| MAPE | Mean absolute percentage error | 0.0538 |
| SAE | Sum of the absolute errors | 30.7925 |
Predictive Modules for Day One
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Day One Biopharmaceu. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Day One's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Day One After-Hype Price Density Analysis
As far as predicting the price of Day One at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Day One or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Day One, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Day One Estimiated After-Hype Price Volatility
In the context of predicting Day One's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Day One's historical news coverage. Day One's after-hype downside and upside margins for the prediction period are 4.86 and 18.70, respectively. We have considered Day One's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Day One is slightly risky at this time. Analysis and calculation of next after-hype price of Day One Biopharmaceu is based on 3 months time horizon.
Day One Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Day One is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Day One backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Day One, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.07 | 6.92 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
11.78 | 11.78 | 0.00 |
|
Day One Hype Timeline
Day One Biopharmaceu is currently traded for 11.78. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Day is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 1.07%. %. The volatility of related hype on Day One is about 0.0%, with the expected price after the next announcement by competition of 11.78. About 17.0% of the company shares are held by company insiders. The book value of Day One was currently reported as 4.39. The company recorded a loss per share of 1.52. Day One Biopharmaceu had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in a few days. Check out Historical Fundamental Analysis of Day One to cross-verify your projections.Day One Related Hype Analysis
Having access to credible news sources related to Day One's direct competition is more important than ever and may enhance your ability to predict Day One's future price movements. Getting to know how Day One's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Day One may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GERN | Geron | 0.00 | 0 per month | 2.94 | 0.03 | 6.72 | (4.76) | 16.99 | |
| VALN | Valneva SE ADR | 0.00 | 0 per month | 2.45 | 0.01 | 4.83 | (4.81) | 15.59 | |
| ARVN | Arvinas | 0.00 | 0 per month | 3.27 | 0.10 | 5.91 | (5.07) | 28.90 | |
| REPL | Replimune Group | 0.00 | 0 per month | 0.00 | (0.16) | 4.82 | (5.32) | 14.00 | |
| TYRA | Tyra Biosciences | 0.00 | 0 per month | 1.66 | 0.25 | 6.05 | (2.98) | 34.11 | |
| RZLT | Rezolute | 0.00 | 0 per month | 15.90 | 0.03 | 18.05 | (9.22) | 99.29 | |
| AVBP | ArriVent BioPharma Common | 0.00 | 0 per month | 3.17 | 0.08 | 6.71 | (6.03) | 18.12 | |
| ATXS | Astria Therapeutics | 0.00 | 0 per month | 1.06 | (0.05) | 2.15 | (1.79) | 6.54 | |
| ERAS | Erasca Inc | 0.00 | 0 per month | 2.61 | 0.32 | 15.04 | (4.76) | 50.26 | |
| VIR | Vir Biotechnology | 0.00 | 0 per month | 3.48 | 0.09 | 8.08 | (6.04) | 20.46 |
Other Forecasting Options for Day One
For every potential investor in Day, whether a beginner or expert, Day One's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Day Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Day. Basic forecasting techniques help filter out the noise by identifying Day One's price trends.Day One Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Day One stock to make a market-neutral strategy. Peer analysis of Day One could also be used in its relative valuation, which is a method of valuing Day One by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Day One Market Strength Events
Market strength indicators help investors to evaluate how Day One stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Day One shares will generate the highest return on investment. By undertsting and applying Day One stock market strength indicators, traders can identify Day One Biopharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 82592.77 | |||
| Daily Balance Of Power | (0.72) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 12.11 | |||
| Day Typical Price | 12.0 | |||
| Price Action Indicator | (0.61) | |||
| Period Momentum Indicator | (0.55) | |||
| Relative Strength Index | 60.81 |
Day One Risk Indicators
The analysis of Day One's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Day One's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting day stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.52 | |||
| Semi Deviation | 3.61 | |||
| Standard Deviation | 6.92 | |||
| Variance | 47.95 | |||
| Downside Variance | 17.03 | |||
| Semi Variance | 13.03 | |||
| Expected Short fall | (6.28) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Day One
The number of cover stories for Day One depends on current market conditions and Day One's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Day One is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Day One's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Day One Short Properties
Day One's future price predictability will typically decrease when Day One's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Day One Biopharmaceuticals often depends not only on the future outlook of the potential Day One's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Day One's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 93.6 M | |
| Cash And Short Term Investments | 531.7 M |
Check out Historical Fundamental Analysis of Day One to cross-verify your projections. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Will Stock sector continue expanding? Could Day diversify its offerings? Factors like these will boost the valuation of Day One. Projected growth potential of Day fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Day One data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Day One Biopharmaceu using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Day One's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Day One's market price to deviate significantly from intrinsic value.
It's important to distinguish between Day One's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Day One should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Day One's market price signifies the transaction level at which participants voluntarily complete trades.